LIFT BIOSCIENCES
LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy. LIfT BioSciences was founded in 2016 and headquartered in London, England.
LIFT BIOSCIENCES
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science Medical Pharmaceutical
Founded:
2016-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.liftbiosciences.com
Total Employee:
1+
Status:
Active
Contact:
+4408712261201
Email Addresses:
[email protected]
Total Funding:
2.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Sectigo SSL Sectigo Domain SSL Wix Wix Forms
Current Advisors List
Current Employees Featured
Founder
Investors List
Shadow Foundr
Shadow Foundr investment in Series A - LIfT BioSciences
KIZOO Technology Capital
KIZOO Technology Capital investment in Series A - LIfT BioSciences
MassChallenge
MassChallenge investment in Non Equity Assistance - LIfT BioSciences
Shadow Foundr
Shadow Foundr investment in Seed Round - LIfT BioSciences
Official Site Inspections
http://www.liftbiosciences.com Semrush global rank: 7.03 M Semrush visits lastest month: 633
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "LIfT BioSciences"
Innate Immunity Cancer Cure Biotech | LIfT BioSciences | United …
LIfT Biosciences is a pre-clinical stage biotech with The World’s only Neutrophil based Cell Therapy Platform. The LIfT platform is allogeneic and can be used to produce different …See details»
Company | Lift Biosciences Cancer Cell Therapy
LIfT is the only biotech company in the world with a Neutrophil Based Cell Therapy Platform (N-LIfT). The N-LIfT platform is flexible & unique which enables us to produce different types of Immuno-Modulatory Alpha Neutrophils …See details»
LIfT BioSciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number +4408712261201 LIfT Biosciences® has a breakthrough allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) that allows us to …See details»
G-Rex® Grant awarded to LIfT Bio - liftbiosciences.com
Oct 9, 2024 · CellReady is the world’s first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell …See details»
LIfT BioSciences - LinkedIn
LIfT Biosciences is a biotech bringing to market a first-in-class alpha neutrophil cell therapy that overcomes the limitations of current therapies in solid tumours by destroying tumours both...See details»
LIfT BioSciences: Contact Details and Business Profile
LIfT BioSciences is a Biotechnology, Biotechnology Research, and Biopharma company_reader located in London, England with 21 employees. Find top employees, contact details and …See details»
LIfT BioSciences unique innate allogeneic cell therapy …
LIfT BioSciences unique innate allogeneic cell therapy against all solid tumors moves to clinical trials. Ground breaking new way to look at cancer results in a ground breaking new cell...See details»
LIfT BioSciences and Minaris Regenerative Medicine Enter into a ...
Feb 16, 2023 · LIfT BioSciences, a pioneering pre-clinical stage company working towards first-in-human trials with an allogeneic neutrophil progenitor based cell therapy, and Minaris …See details»
LIfT BioSciences raises £10m in first close of Series A to
Sep 24, 2024 · LIfT is developing a breakthrough allogeneic innate cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT), that produces a new type of myeloid cell …See details»
LIfT BioSciences - Craft
See insights on LIfT BioSciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Investor Information | Lift Biosciences Cancer Cell Therapy
We are interested in investors joining the syndicate who personally share our mission to develop a cure for all solid tumours, and who can make a positive contribution to the future direction of …See details»
Transferring innate immunity to destroy cancers - Nature
LIfT BioSciences’ unique cell therapy against all solid tumors moves to clinical trials. A decisive factor in whether mutating cells develop into a tumor is the effectiveness of the immune...See details»
LIfT BioSciences Wins the Support of The European Institute for ...
As one of three winners at The EIT Health Summit, LIfT BioSciences now benefits from being a part of the prestigious EIT Accelerator System and the Infrastructure that accompanies that, …See details»
LIfT BioSciences - PitchBook
Developer of a biotech platform designed for CAR neutrophil cell therapy that helps overcome the limitations of current therapies in solid tumours.See details»
LIfT BioSciences heralds a new era of affordable effective
Jun 7, 2023 · LIfT Biosciences is a biotech bringing to market a first-in-class alpha neutrophil cell therapy that overcomes the limitations of current therapies in solid tumours by destroying …See details»
Lift BioSciences Announces Abstract Publications at the American ...
May 24, 2024 · Our findings demonstrate the successful multimodal mechanisms of action of our IMANs and their capability to immunomodulate the solid tumour microenvironment for long …See details»
LIfT BioSciences heralds a new era of affordable effective cancer …
Jul 6, 2023 · LIfT Biosciences is a biotech bringing to market a first-in-class alpha neutrophil cell therapy that overcomes the limitations of current therapies in solid tumours by destroying …See details»
LIfT BioSciences announces breakthrough preclinical data
Mar 21, 2023 · LIfT Biosciences is a biotech bringing to patients a first -in-class allogeneic innate cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT).See details»
LIfT BioSciences secures its largest financing to date with a further …
London, 21st January 2022 – Biotech LIfT BioSciences today announced its largest financing round to date with a further £5m investment into the company in its mission to develop the first …See details»
LIfT BioSciences - VentureRadar
Website: https://www.liftbiosciences.com Develops first-in-class immuno-oncology cell therapy using Leukocyte Infusion Therapy (LIfT) for solid tumors, transforming unscalable medical …See details»